| http://www.w3.org/ns/prov#value | - Previous efforts aimed at managing these risks, including the addition of a boxed warning in 2003, have not adequately addressed this safety issue, so the FDA is now requiring changes to the drug's label as part of a risk evaluation and mitigation strategy (REMS) for these products.
|
